Fresenius Medical Care AG Stock
Stocks
FME
DE0005785802
Healthcare Facilities & Services
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.99 EUR | +0.71% |
|
+6.24% | +0.69% |
| 06-09 | FMC FRESENIUS MEDICAL CARE AG : UBS keeps a Sell rating | ZD |
| 06-08 | Clínica Baviera, the copy-paste machine |  |
| Market Cap | 10.93B 12.68B 10.06B 9.44B 17.73B 1,199B 17.9B 119B 46.46B 587B 47.59B 46.58B 2,031B | P/E Ratio 2026 * |
13.4x | P/E Ratio 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 19.75B 22.91B 18.17B 17.05B 32.02B 2,165B 32.34B 215B 83.92B 1,060B 85.97B 84.15B 3,669B | EV / Sales 2026 * |
1.02x | EV / Sales 2027 * | 0.97x |
| Free-Float |
60.09% | Yield 2026 * |
3.41% | Yield 2027 * | 3.73% |
Last Transcript: Fresenius Medical Care AG
| 1 day | +0.72% | ||
| 1 week | +6.24% | ||
| Current month | +10.35% | ||
| 1 month | +7.66% | ||
| 3 months | +2.78% | ||
| 6 months | +2.14% | ||
| Current year | +0.69% |
| 1 week | 38.34 |  | 41.09 |
| 1 month | 35.32 | | 41.09 |
| Current year | 34.57 | | 41.79 |
| 1 year | 34.57 | | 49.72 |
| 3 years | 30.16 | | 54.02 |
| 5 years | 25.95 | | 71.14 |
| 10 years | 25.95 | | 93.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 58 | 06/12/2022 |
Martin Fischer
DFI | Director of Finance/CFO | 48 | 01/10/2023 |
| Chief Tech/Sci/R&D Officer | 56 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 59 | 12/05/2016 |
A. Sorensen
BRD | Director/Board Member | 64 | 20/05/2021 |
Michael Sen
CHM | Chairman | 57 | 14/07/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-18 | Buy | Chief Executive Officer | 11,398 | 0.0039% | ||
| 19/03/25 | Buy | Chief Technology Officer | 777 | 0.0003% | ||
| 19/03/25 | Buy | Executive/Senior Manager | 901 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | +6.24% | -17.07% | -5.57% | 12.68B | |
| -0.73% | +2.76% | +47.30% | +47.28% | 128B | |
| +2.02% | +5.63% | +7.43% | +36.51% | 86.51B | |
| -0.26% | +3.95% | -12.14% | +49.42% | 25.39B | |
| +0.78% | -0.84% | +11.39% | +46.33% | 22.38B | |
| +0.06% | -2.43% | +0.26% | +12.96% | 21.73B | |
| 0.00% | +3.40% | -16.21% | -20.59% | 20.4B | |
| +1.59% | +9.34% | +10.75% | +131.93% | 15.43B | |
| +0.18% | +1.26% | -4.95% | +1.59% | 14.71B | |
| -1.05% | +4.75% | +50.62% | +112.67% | 13.47B | |
| Average | +0.28% | +5.35% | +7.74% | +41.25% | 36.12B | |
| Weighted average by Cap. | +0.26% | +5.16% | +19.10% | +41.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 19.44B 22.56B 17.89B 16.79B 31.53B 2,132B 31.85B 212B 82.63B 1,044B 84.65B 82.86B 3,612B | 20.14B 23.37B 18.54B 17.39B 32.66B 2,208B 32.99B 219B 85.59B 1,081B 87.69B 85.83B 3,742B |
| Net income | 836M 970M 769M 722M 1.36B 91.67B 1.37B 9.1B 3.55B 44.89B 3.64B 3.56B 155B | 1.07B 1.24B 985M 924M 1.74B 117B 1.75B 11.65B 4.55B 57.48B 4.66B 4.56B 199B |
| Net Debt | 8.82B 10.23B 8.11B 7.61B 14.3B 967B 14.44B 95.91B 37.47B 473B 38.38B 37.57B 1,638B | 8.69B 10.08B 8B 7.5B 14.09B 953B 14.23B 94.54B 36.93B 467B 37.83B 37.03B 1,614B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 41.09 € | +0.96% | 366,146 |
| 15/06/26 | 40.70 € | +2.60% | 912,418 |
| 12/06/26 | 39.67 € | +2.51% | 964,834 |
| 11/06/26 | 38.70 € | -0.33% | 990,466 |
| 10/06/26 | 38.83 € | +0.52% | 932,889 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FME Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition